# Tasca Therapeutics Corp — Form D/A

Tasca Therapeutics Corp of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2025-12-01. The offering totals $70.2M, of which $48.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-12-01
- Form: D/A
- Accession: 0002046762-25-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $70.2M
- Amount sold: $48.1M
- Remaining: $22.1M
- Investors: 9
- Date of first sale: 2024-11-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-530757

## Issuer

- Name: Tasca Therapeutics Corp
- CIK: 0002046762
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 55 SPINELLI PLACE, CAMBRIDGE, MA, 02138
- Phone: 617-390-4306

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Michael Aberman | Director | Cambridge, MA |
| Milenko Cicmil | Director | Cambridge, MA |
| David Fallace | Director | BOSTON, MA |
| Seth Lieblich | Director | Cambridge, MA |
| Praveen Tipirneni | Director | Cambridge, MA |
| Xu Wu | Director | Cambridge, MA |
| Milenko Cicmil | Executive Officer | Cambridge, MA |
| Drew King | Executive Officer | Cambridge, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-11-29](https://search.stillhousedata.com/formd/0002046762-24-000001) | D | $70.2M | $24.1M |

## More

- [CIK 2046762 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2046762&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002046762-25-000005.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.